The FDA just published: Guidance for Industry – Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification (PDF)
William Koustas (FDA Law Blog) writes, “The DSCSA tasked FDA with addressing three issues in this guidance: (1) identifying scenarios that could increase the risk of suspect product entering the supply chain; (2) recommending ways trading partners can identify and determine whether product is suspect; and (3) creating a process for trading partners to terminate illegitimate product notifications. FDC Act § 582(h)(2). The Draft Guidance addressed each of these three issues as follows:” . . .
Read the full article: via FDA Law Blog: And So It Begins: FDA Issues First DSCSA Guidance.
Go to DREprof.com: The Designated Representative and Exemptee Training Website
- CA Designated Representative online web-based training certification by SkillsPlus Intl Inc. – Available around-the-clock 24 x 7 – Available for iPad
- FL Certified Designated Representative (CDR) online exam prep course by SkillsPlus Intl Inc. – Lots of practice exams – Practice makes perfect! – Available around-the-clock 24 x 7
- The Designated Representative Institute
- CA HMDR Exemptee online internet-based training certification by SkillsPlus Intl Inc. – Enhanced for iPad
- The Exemptee Institute